Fractyl Health (GUTS) Receivables - Net (2023 - 2024)
Fractyl Health (GUTS) recorded quarterly Receivables - Net of $22000.0 in Q2 2024, up 46.67% on a QoQ basis from $15000.0 in Q1 2024.
Powered by 
Analysis
Fractyl Health (GUTS) Receivables - Net (2023 - 2024) Analysis & Trends
Fractyl Health (GUTS) has reported Receivables - Net for 2 consecutive years, with $22000.0 the latest figure, recorded in Q2 2024.
- For the quarter ending Q2 2024, Receivables - Net changed N/A year-over-year to $22000.0; the trailing twelve-month figure through Jun 2024 stood at $22000.0 (changed N/A YoY), and the FY2023 full-year result was $22000.0, changed N/A from the prior year.
- Receivables - Net was $22000.0 for Q2 2024 at Fractyl Health, up from $15000.0 in the prior quarter.
- The five-year high for Receivables - Net was $22000.0 in Q4 2023, with the low at $15000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Fractyl Health | 102.41 Mn | 102.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 22,000.00 |